Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor

Niels Vande Casteele, Maria T. Abreu, Sarah Flier, Konstantinos Papamichael, Florian Rieder, Mark S. Silverberg, Reena Khanna, Lauren Okada, Lei Yang, Anjali Jain, Adam S. Cheifetz

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
JournalClinical Gastroenterology and Hepatology
StateAccepted/In press - 2021
Externally publishedYes

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this